Trends in the Incidence of Cancer in Iran (2003 - 2009)
Journal Title: International Journal of Cancer Management - Year 2017, Vol 10, Issue 2
Abstract
Background Cancer is a leading cause of death throughout the world. Increasing life expectancy and aging population are important factors for increasing cancer incidences in developing countries. National programs are essential for prevention and control of cancer in any society. Objectives This study aimed to investigate cancer incidence and trend of its changes in Iran. Methods National incidence was rated by Iran national cancer registry data derived from Iran’s annual national cancer registration reported from 2003 to 2009. The crude rate and age standardized rate were used to express the incidence of cancer. Cochrane Armitage test was used for linear trend by Winpepi software 2.1 to study the trends in cancer incidence. Results Based on the results of this study, the incidence of cancer was rising in Iran from 2003 to 2009 and the sex ratio was more in men than women. During this time a total of 413591 cases of cancer have been registered in the country. Of the incidence cases, 231572 cases were males and 182019 were females. Conclusions This study indicated remarkable increasing trends in cancer incidence. According to changing lifestyles and dietary habits, it is possible that in the coming years we will be faced with a higher incidence of cancer in the country, Therefore, it is recommended to promote the use of screening programs and to increase awareness of the population to reduced the incidence of cancer in the country.
Authors and Affiliations
Seideh Zeinab Almasi, Hamid Salehiniya, Neda Amoori, Sepideh Mahdavi, Mostafa Enayatrad
Keywords
Related Articles
- EP ID EP237296
- DOI 10.5812/ijcp.4715
- Views 75
- Downloads 0
Effect of Simultaneous Treatment with Royal Jelly and Doxorubicin on the Survival of the Prostate Cancer Cell Line (PC3): An In Vitro Study
Background: Doxorubicin (DOX) therapy is the first step in the treatment of several malignancies such as prostate cancer. Drug resistance is the main drawback of this agent. Royal jelly (RJ), used to prevent or cure many...
Two Side Effects of Sutent Therapy in Renal Cell Carcinoma: A Case Report
Introduction Renal cell carcinoma (RCC) has known as the most frequent urological malignancy among adults, which occured mostly among male patients. Sunitinib malate (SUTENT<sup>®...
Production of Specific Anti-EGFR Single Chain Antibodies: A Promising Strategy in the Immunotherapy of EGFR Expressing Tumor Tissues
Background: EGFR (Epidermal growth factor receptor) is overexpressed in a number of cancers and plays an important role in several phenomena such as aggressiveness of tumor, decreased survival of the patient, and resista...
Evaluation of Tumor Resectability Rate and Pathologic Response to Preoperative Concurrent Chemoradiotherapy in Locally Advanced Proximal Gastric and Esophagogastric Junction Adenocarcinomas: A Clinical Trial
Background: Preoperative concurrent chemoradiotherapy may improve surgical results and patient survival rates in gastric adenocarcinomas. We aimed to assess tumor resectability and pathologic response rates in patients w...
Comparative Proteomic Analysis of Breast Cancer Tissue and the Adjacent Normal Tissue in Iranian Patients with HER2 Negative Ductal Carcinoma of Breast
Background: There is very limited evidence about the differences between proteome of breast cancer tissue and the adjacent normal tissue. Given the importance of identifying factors involved in the tumorogenesis of breas...